Bristol-Myers Squibb (BMY)
61.12
1.10 (1.83%)
At close: Mar 31, 2025, 3:59 PM
60.87
-0.40%
After-hours: Mar 31, 2025, 07:46 PM EDT
Eliquis Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2023 | 3.2B | -219M | -6.40% |
| Mar 31, 2023 | 3.42B | 735M | +27.34% |
| Dec 31, 2022 | 2.69B | 33M | +1.24% |
| Sep 30, 2022 | 2.65B | -580M | -17.93% |
| Jun 30, 2022 | 3.23B | 3.22B | +17872.22% |
| Mar 31, 2022 | 18M | -2M | -10.00% |
| Dec 31, 2021 | 20M | -2M | -9.09% |
| Sep 30, 2021 | 22M | 6M | +37.50% |
| Jun 30, 2021 | 16M | -1.7B | -99.07% |
| Mar 31, 2021 | 1.72B | -73M | -4.07% |
| Dec 31, 2020 | 1.79B | 13M | +0.73% |
| Sep 30, 2020 | 1.78B | 1.03B | +137.33% |
| Jun 30, 2020 | 750M | 36M | +5.04% |
| Mar 31, 2020 | 714M | 329M | +85.45% |
| Dec 31, 2019 | 385M | 32M | +9.07% |
| Sep 30, 2019 | 353M | -14M | -3.81% |
| Jun 30, 2019 | 367M | -17M | -4.43% |
| Mar 31, 2019 | 384M | n/a | n/a |
| Dec 31, 2018 | 384M | 2M | +0.52% |
| Sep 30, 2018 | 382M | 67M | +21.27% |
| Jun 30, 2018 | 315M | 66M | +26.51% |
| Mar 31, 2018 | 249M | -20M | -7.43% |
| Dec 31, 2017 | 269M | -54M | -16.72% |
| Sep 30, 2017 | 323M | 1M | +0.31% |
| Jun 30, 2017 | 322M | -8M | -2.42% |
| Mar 31, 2017 | 330M | 66M | +25.00% |
| Dec 31, 2016 | 264M | -21M | -7.37% |
| Sep 30, 2016 | 285M | 44M | +18.26% |
| Jun 30, 2016 | 241M | -22M | -8.37% |
| Mar 31, 2016 | 263M | -2M | -0.75% |
| Dec 31, 2015 | 265M | 25M | +10.42% |
| Sep 30, 2015 | 240M | -56M | -18.92% |
| Jun 30, 2015 | 296M | -29M | -8.92% |
| Mar 31, 2015 | 325M | -41M | -11.20% |
| Dec 31, 2014 | 366M | 16M | +4.57% |
| Sep 30, 2014 | 350M | n/a | n/a |
| Jun 30, 2014 | n/a | n/a | n/a |
| Mar 31, 2014 | n/a | n/a | n/a |
| Dec 31, 2013 | n/a | n/a | n/a |
| Sep 30, 2013 | n/a | n/a | n/a |
| Jun 30, 2013 | n/a | n/a | n/a |